ArticleExpression of Matrix Metalloproteinase 1(MMP1) in HepatoCellular Carcinoma (HCC): Immunohistochemical and Biochemical Studies
ArticleExpression of Matrix Metalloproteinase 1(MMP1) in HepatoCellular Carcinoma (HCC): Immunohistochemical and Biochemical Studies
ArticleImmunohistochemical expression of matrix metalloproteinase-9 in urothelial carcinoma of urinary bladder
ArticleImmunohistochemical expression of matrix metalloproteinase-9 in urothelial carcinoma of urinary bladder
ArticleEpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study
ArticleEpCAM Expression in Epithelial Ovarian Cancer: Immunohistochemical and Histopathological Study
ArticleAssessment of Galectins -1, -2, -3, and -8 Expression in Endometrial Carcinoma and Its Clinical Implications
ArticleAssessment of Galectins -1, -2, -3, and -8 Expression in Endometrial Carcinoma and Its Clinical Implications
ArticleRRBP1 Expression in wild and mutated p53 immunophenotype endometrioid endometrial carcinoma: Relation to ER-α and clinicopathologic factors
ArticleRRBP1 Expression in wild and mutated p53 immunophenotype endometrioid endometrial carcinoma: Relation to ER-α and clinicopathologic factors
ArticleIMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN RECEPTORS AS PROGNOSTIC MARKER AND CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS IN HUMAN ENDOMETRIAL ADENOCARCINOMA
ArticleIMMUNOHISTOCHEMICAL EXPRESSION OF ESTROGEN RECEPTORS AS PROGNOSTIC MARKER AND CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS IN HUMAN ENDOMETRIAL ADENOCARCINOMA
ArticleA Comprehensive Clinicopathological Analysis of Carcinoma of Endometrium: Histotype- Immunophenotype Correlation
ArticleA Comprehensive Clinicopathological Analysis of Carcinoma of Endometrium: Histotype- Immunophenotype Correlation
ArticleEMMPIRRIN (CD147) and matrix metalloproteinase-9 (MMP9) immunohistochemical expression in breast carcinoma: Relationship with clinicopathological paremeters
ArticleEMMPIRRIN (CD147) and matrix metalloproteinase-9 (MMP9) immunohistochemical expression in breast carcinoma: Relationship with clinicopathological paremeters